Table 1.
Patient demographics and COVID-19 treatments.
| Non-Severe COVID-19 |
Severe COVID-19 | p value | ||
|---|---|---|---|---|
| N | 14 | 16 | ||
| Age (Median, range) |
54 (25-87) | 58 (26-91) | 0.55 | |
| Sex (%, N) |
64.3% (9) M 35.7% (5) F |
68.8% (11) M 31.3% (5) F |
>0.99 | |
| Race (%, N) |
||||
| White | 35.7% (5) | 37.5% (6) | >0.99 | |
| African American | 7.1% (1) | 12.5% (2) | >0.99 | |
| Asian | 0% (0) | 6.3% (1) | >0.99 | |
| Native American | 0% (0) | 6.3% (1) | >0.99 | |
| Multiple | 28.6% (4) | 12.5% (2) | 0.38 | |
| Unknown | 28.6% (4) | 25.0% (4) | >0.99 | |
| Ethnicity (%, N) |
Hispanic | 57.1% (8) | 62.5% (10) | >0.99 |
| Comorbidities (%, N) |
||||
| BMI (Median, range, N) |
35.3 (30-57.6) (n=7) |
30.2 (21-42.8) (n=15) |
0.18 | |
| Diabetes | 64.3% (9) | 56.3% (9) | 0.72 | |
| Hypertension | 28.3% (4) | 37.5% (6) | 0.71 | |
| Malignancy | 14.3% (2) | 12.5% (2) | >0.99 | |
| Immune Suppressed | 0% (0) | 6.3% (1) | >0.99 | |
| Lung Disease | 0% (0) | 18.8% (3) | 0.23 | |
| HIV+ | 7.1% (1) | 0% (0) | 0.47 | |
| Pregnancy | 7.1% (1) | 0% (0) | 0.47 | |
| # Of Comorbidities (Median, range) | 1.3 (0-4) | 1.5 (0-5) | 0.64 | |
| Supplemental Oxygen Support (%, N) | ||||
| Nasal Canula | 78.6% (11) | 0% (0) | <0.01 | |
| Face Mask | 7.1% (1) | 0% (0) | 0.47 | |
| Humidified High Flow Nasal Canula | 14.3% (2) | 18.8% (3) | >0.99 | |
| Non-rebreather Mask | 0% (0) | 6.3% (1) | >0.99 | |
| Mechanical Ventilation | 0% (0) | 43.8% (7) | 0.01 | |
| ECMO | 0% (0) | 31.3% (5) | 0.04 | |
| Length of Hospitalization (Median, range) | 10.4 (4-42) | 25.8 (5-46) | <0.01 | |
| ICU Admission (%, N) |
0% (0) | 100% (16) | <0.01 | |
| COVID19 Treatment (%, N) |
||||
| Anticoagulation | 50.0% (7) Enoxaparin (6) Heparin (1) |
87.5% (14) Lovenox (3) Heparin (7) Warfarin (1) Enoxaparin (1) Angiomax (1) |
0.05 | |
| Corticosteroids | 0% (0) | 31.3% (5) Dexamethasone (4) Hydrocortisone (1) |
0.04 | |
| Remdesivir | 35.7% (5) | 0% (0) | 0.01 | |
| Monoclonal Antibody | 0% (0) | 6.25% (1) Tocilizumab (1) |
>0.99 | |
| Convalescent Plasma | 100% (14) | 100% (16) | >0.99 | |
| Inpatient Mortality (%, N) |
0% (0) | 31.3% (5) | 0.04 | |
| Hospital Day of Blood Draw (Median, range) | 5 (2-16) | 10 (1-31) | 0.78 | |
p values were generated through T test or Fisher exact test comparing non-severe vs. severe patients.
p values less than 0.05 are highlighted in bold font.